Physician profile
Jun Kim
NPI 1841638699
$18,845.93
in general payments reported to CMS, 2019-2025
23 companies · $688 in 2025
The $688 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,077 · 2021: $1,479 · 2022: $345 · 2023: $633 · 2024: $2,319 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,560 · Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,559.51 |
| Food and Beverage | $1,081.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,411.34 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $4,573.62 | 2019-2025 | Persona, Rosa, Avenir |
| Stryker Corporation | $1,187.74 | 2019-2025 | Mako, Insignia |
| Sequoia Surgical, INC. | $561.00 | 2019 | |
| Medical Device Business Services, INC. | $328.55 | 2019-2024 | Vistaseal |
| Depuy Synthes Sales INC. | $190.74 | 2019-2021 | |
| Amplify Surgical, INC. | $120.67 | 2023 | Dualx and Dualportal |
| Pacira Therapeutics, INC. | $112.98 | 2019-2021 | |
| Nuvasive, INC. | $69.10 | 2019-2020 | |
| Becton, Dickinson and Company | $36.62 | 2024 | Arista Ah Flexitip |
| Ortho Development Corporation | $36.10 | 2021 | |
| Nalu Medical, INC. | $28.09 | 2025 | Nalu Neurostimulation System |
| Ferring Pharmaceuticals INC. | $26.94 | 2019-2021 | |
| Orthofix Medical, INC. | $24.86 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.10 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $16.05 | 2025 | |
| Kci USA, INC. | $15.73 | 2019 | |
| Si-Bone, INC. | $15.73 | 2021 | |
| Glaxosmithkline, LLC. | $15.52 | 2025 | Trelegy Ellipta |
| Heron Therapeutics, INC. | $15.08 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2021 | |
| Vanda Pharmaceuticals INC. | $14.87 | 2025 | Fanapt |
| Boston Scientific Corporation | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.